Kingdon Capital Management, L.L.C. Axsome Therapeutics, Inc. Put Options Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $5.44 Million - $11.7 Million	250,000 New	250,000 $9.58 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $2.51 Million - $15.9 Million	-150,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $3.04 Million - $4.37 Million	150,000 New	150,000 $3.04 Million

327

38M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.